CSL gains exclusive rights to RAPIVAB

CSL Ltd. recently announced that it now has exclusive rights to commercialize RAPIVAB, the influenza treatment that was created by BioCryst Pharmaceuticals Inc. Read More »

Boudreaux joins Novavax Board of Directors

Novavax Inc., a clinical-stage vaccine company that specializes on discovering, creating and commercializing recombinant nanoparticle vaccines and adjuvants, recently announced that it has chosen added Gail Boudreaux to the company’s board of directors. Read More »

FDA clears HPV vaccine for Phase 1 clinical study

The United States Food and Drug Administration (FDA) recently announced that it has cleared a Phase 1 clinical study of GTL001, also called ProCervix, a human papillomavirus (HPV) vaccine made by Genticel, a French biotechnology company and developer of novel immunotherapies designed to prevent HPV cancers. Read More »

Study finds new genetic immune disorder

A team of scientists whose research was funded with the National Institutes of Health's (NIH) National Institute of Allergy and Diseases (NIAID) discovered a new immune disorder that causes DOCK2, a specific gene, to mutate and cause DOCK2 deficiency, the NIH said Wednesday. Read More »

Longboat gives Greater Gift Initiative 980 vaccines

The Greater Gift Initiative (GGI) recently announced that it has received 980 vaccines by means of a donation from Longboat. Read More »

Summer flu season begins in Hong Kong

The Center for Health Protection (CHP), a branch of the Department of Health, recently urged the public of Hong Kong to remain wary of seasonal influenza due to new data about the upcoming summer influenza season. Read More »

U.N. health agency heightens response to cholera outbreak in Tanzania

The United Nations health agency recently stated that it the cholera outbreak in Tanzania has continued spreading through Tanzania’s western Kigoma region due to an increase in refugees from nearby Burundi. Read More »

Epidemiological update on MERS-CoV from South Korea

The South Korean Center for Disease Control and Prevention recently reported a new Middle East respiratory syndrome coronavirus (MERS-CoV) case. Read More »

Synthetic vaccine particles may be crucial to mucosal vaccine research

Selecta Biosciences Inc., a clinical stage biotechnology company that is developing an innovative class of targeted antigen-specific immune therapies with synthetic vaccine particles (SVPs), recently announced that SVP may be crucial to developing an innovative vaccine technology targeting mucosal tissues. Read More »

AIDS vaccine candidate successfully stimulates immune system

A team of researchers from The Scripps Research Institute (TSRI), the Rockefeller University and International AIDS Vaccine Initiative recently conducted a study that shows an experimental AIDS vaccine candidate can successfully stimulate the immune system to halt HIV infections. Read More »

New malaria genetics approach to fight drug-resistant parasites

A tool was recently created to improve scientific understanding of malaria resistance by using malaria genetic cross with a humanized mouse model and mosquitoes. Scientists want to understand how the drug resistance arises, how virulence increases, and how parasites mate in order to improve parasite control and save countless people. Read More »

Pfizer to buy meningitis vaccines from GlaxoSmithKline

Pfizer Inc. recently announced that it has made an agreement with GlaxoSmithKline to acquire Nimenrix and Mencevax vaccines for meningitis A, C, W135 and Y. Read More »

Researchers seek Rocky Mountain Spotted Fever prevention and treatment

A recent study, conducted by the Centers for Disease Control and Prevention (CDC), the Indian Health Service (IHS) and Arizona tribes, shows that preventing and treating Rock Mountain Spotted Fever (RMSF) early will save both lives and costs. Read More »

Indiana health officials determine long-term plan for HIV outbreak

Indiana health officials met on June 16 to discuss the long-term planning process to address the transition and response to the HIV outbreak that occurred in the southeastern region of the state. Read More »

HIV vaccine study produces antibodies in animal subjects

Three study teams recently showed that they have developed an HIV vaccine that produces relevant antibodies to fight HIV within animal cells. Read More »

Innovative hepatitis surveillance tools improve Florida reporting

The Florida Department of Health has created surveillance tools to detect hepatitis cases throughout the state. Read More »

ASU center seeks potential vaccine for tularemia

A team of experts led by Petra Fromme, director of Arizona State University’s Center for Membrane Proteins in Infectious Diseases, is examining a key component responsible for the infectious character of tularemia, where the pathogen involved could be used as a biological weapon. Tularemia is a potentially fatal bacterial infection caused by the bacterium Francisella tularensis. Read More »

HIV vaccine uses specially designed proteins

A team of researchers from the National Institutes of Health (NIH) have created a new HIV vaccine, which uses specially shaped proteins that are meant to induce a response from the immune system. Read More »

Thermo Fisher Scientific opens manufacturing site in Scotland

According to a recent announcement, Thermo Fisher Scientific, a global leader in serving science, has opened its media manufacturing site in Scotland. Read More »

Second measles case of 2015 confirmed in Massachusetts

The Massachusetts Department of Public Health (MDPH) recently confirmed the second measles case in Massachusetts for 2015. Read More »